Gritstone Oncology to Webcast Investor Event Reviewing its Neoantigen-based Immunotherapies During SITC Conference
Gritstone bio, Inc. (GRTS)
Last gritstone bio, inc. earnings: 11/12 09:01 am
Check Earnings Report
Company Research
Source: GlobeNewswire
EMERYVILLE, Calif., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, today announced that it will webcast an investor event with its executive management team on Friday, November 8, 2019 from 6:00-8:00 p.m. ET. The event will focus on the company’s clinical-stage immunotherapies, GRANITE and SLATE, including an overview of the ongoing trials as well as the type of preliminary immunogenicity and safety data the company expects to have for presentation at the European Society for Medical Oncology’s Immuno-Oncology Congress (ESMO-IO) in December. The studies are on-track for completion in 2020 with data expected in mid-2020. The company will also review the novel shared neoantigens contained within its first SLATE product candidate that will be presented at the Society for Immunotherapy of Cancer (SITC) Conference in National Harbor, MD
Show less
Read more
Impact Snapshot
Event Time:
GRTS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GRTS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GRTS alerts
High impacting Gritstone bio, Inc. news events
Weekly update
A roundup of the hottest topics
GRTS
News
- Gritstone bio Takes Action to Preserve Value and Strengthen Capital StructureBusiness Wire
- Gritstone bio, Inc. (NASDAQ: GRTS) was downgraded by analysts at B. Riley from a "strong-buy" rating to a "hold" rating.MarketBeat
- Gritstone bio, Inc. (NASDAQ: GRTS) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.MarketBeat
- Gritstone bio, Inc. (NASDAQ: GRTS) had its "neutral" rating re-affirmed by analysts at B. Riley. They now have a $1.00 price target on the stock, down previously from $3.00.MarketBeat
- Gritstone bio, Inc. (NASDAQ: GRTS) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $0.50 price target on the stock, down previously from $4.00.MarketBeat
GRTS
Earnings
- 8/13/24 - Beat
GRTS
Sec Filings
- 10/16/24 - Form 8-K
- 10/10/24 - Form 8-K
- 10/7/24 - Form SC
- GRTS's page on the SEC website